CTXR — Citius Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Citius Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	R2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	—	—	—	—	—
Source:	10-Q	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	7.89	13.9	70.1	41.7	26.5
Prepaid Expenses
Total Current Assets	7.94	14	72.8	44.6	34.4
Net Property, Plant And Equipment	0.001	0.988	0.83	0.65	0.456
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	36.7	43.8	142	114	104
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	4.61	4.1	3.98	4.53	5.78
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	9.59	10.1	10.2	11.2	12.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	27.2	33.7	132	103	90.8
Total Liabilities & Shareholders' Equity	36.7	43.8	142	114	104
Total Common Shares Outstanding